Biotech Finances

The French Biotech Finances newsletter was created in 1999 and has become the clear market-leader in business information among bio-industry decision-makers and investors. Each year, more than 400,000 stakeholders from the life sciences sector around the world read the newsletter and access its online information and databases. Over the years we have had frequent requests for an English-language version. Now we have launched the English language version, which we are confident will soon become the leading English-language information source in its field.

SUBSCRIBE NOW click here.

Why is Biotech Finances different?

In Biotech Finances we don't recycle news stories that have already been published elsewhere. We have a team of specialists who actually talk to key players in the field, such as CEOs of leading companies, politicians and regulators. As a result, you'll find news in Biotech Finances that you won't find elsewhere. In addition, our tables of financial transactions in the biotechnology field provide early notification of key M&A activity in the sector. Ultimately, Biotech Finances provides the information your business needs to succeed in the dynamic field of biotechnology.

SUBSCRIBE NOW click here.

Save money and make sure you get every issue with a cost-effective subscription

Don't forget to purchase Biotech Finances next week, or better still, to make sure you get every issue, take out a cost-effective subscription to Biotech Finances. You'll also get complementary access to our complete archive and online news database, which is a real goldmine of data about the biotech industry.

SUBSCRIBE NOW click here.